Literature DB >> 11000243

DNA vaccination prevents and/or delays carcinoma development of papillomavirus-induced skin papillomas on rabbits.

R Han1, N M Cladel, C A Reed, X Peng, L R Budgeon, M Pickel, N D Christensen.   

Abstract

Malignant progression is a life-threatening consequence of human papillomavirus-associated lesions. In this study, we tested the efficacy of papillomavirus early-gene-based vaccines for prevention of carcinoma development of papillomavirus-induced skin papillomas on rabbits. Rabbit skin papillomas were initiated by infection with cottontail rabbit papillomavirus (CRPV). The papillomas were allowed to grow for 3 months without any treatment intervention. Rabbits were then immunized by gene gun-mediated intracutaneous administration of four DNA plasmids encoding CRPV E1, E2, E6, and E7 genes, respectively. All eight control rabbits receiving vector alone developed invasive carcinoma within 8 to 13 months. In contrast, only two of eight vaccinated rabbits developed carcinoma at 12 and 15 months, respectively. Papilloma growth was suppressed in the majority of vaccinated rabbits but not completely eradicated. These results indicate that gene gun-mediated immunization with papillomavirus early genes may be a promising strategy for prevention of malignant progression of human papillomavirus-associated lesions in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000243      PMCID: PMC112403          DOI: 10.1128/jvi.74.20.9712-9716.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  DNA-based immunization by in vivo transfection of dendritic cells.

Authors:  C Condon; S C Watkins; C M Celluzzi; K Thompson; L D Falo
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

2.  Regression of papillomas induced by cottontail rabbit papillomavirus is associated with infiltration of CD8+ cells and persistence of viral DNA after regression.

Authors:  R Selvakumar; A Schmitt; T Iftner; R Ahmed; F O Wettstein
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

Review 4.  Cancer immunotherapy: synthetic and natural peptides in the balance.

Authors:  M Bellone; G Iezzi; M A Imro; M P Protti
Journal:  Immunol Today       Date:  1999-10

5.  The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells.

Authors:  A Schmitt; A Rochat; R Zeltner; L Borenstein; Y Barrandon; F O Wettstein; T Iftner
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Intramuscular injection of plasmid DNA encoding cottontail rabbit papillomavirus E1, E2, E6 and E7 induces T cell-mediated but not humoral immune responses in rabbits.

Authors:  R Han; C A Reed; N M Cladel; N D Christensen
Journal:  Vaccine       Date:  1999-03-17       Impact factor: 3.641

7.  Tumor regression is associated with a specific immune response to the E2 protein of cottontail rabbit papillomavirus.

Authors:  R Selvakumar; R Ahmed; F O Wettstein
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

8.  Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes.

Authors:  R Han; F Breitburd; P N Marche; G Orth
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

9.  Identification of three transforming proteins encoded by cottontail rabbit papillomavirus.

Authors:  C Meyers; J Harry; Y L Lin; F O Wettstein
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

Authors:  F Breitburd; R Kirnbauer; N L Hubbert; B Nonnenmacher; C Trin-Dinh-Desmarquet; G Orth; J T Schiller; D R Lowy
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  16 in total

1.  Mucosally delivered peptides prime strong immunity in HLA-A2.1 transgenic rabbits.

Authors:  Jiafen Hu; Nancy Cladel; Karla Balogh; Neil Christensen
Journal:  Vaccine       Date:  2010-03-21       Impact factor: 3.641

2.  Secondary infections, expanded tissue tropism, and evidence for malignant potential in immunocompromised mice infected with Mus musculus papillomavirus 1 DNA and virus.

Authors:  Nancy M Cladel; Lynn R Budgeon; Timothy K Cooper; Karla K Balogh; Jiafen Hu; Neil D Christensen
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

Review 3.  Micro-scale devices for transdermal drug delivery.

Authors:  Anubhav Arora; Mark R Prausnitz; Samir Mitragotri
Journal:  Int J Pharm       Date:  2008-08-30       Impact factor: 5.875

4.  Using HLA-A2.1 Transgenic Rabbit Model to Screen and Characterize New HLA-A2.1 Restricted Epitope DNA Vaccines.

Authors:  Jiafen Hu; Todd D Schell; Xuwen Peng; Nancy M Cladel; Karla K Balogh; Neil D Christensen
Journal:  J Vaccines Vaccin       Date:  2010-08-20

5.  Orf Virus-Based Therapeutic Vaccine for Treatment of Papillomavirus-Induced Tumors.

Authors:  M Schneider; M Müller; A Yigitliler; J Xi; C Simon; T Feger; H-J Rziha; F Stubenrauch; H-G Rammensee; T Iftner; R Amann
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

6.  Combination treatment with intralesional cidofovir and viral-DNA vaccination cures large cottontail rabbit papillomavirus-induced papillomas and reduces recurrences.

Authors:  N D Christensen; R Han; N M Cladel; M D Pickel
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

7.  Intracutaneous DNA vaccination with the E8 gene of cottontail rabbit papillomavirus induces protective immunity against virus challenge in rabbits.

Authors:  Jiafen Hu; Ricai Han; Nancy M Cladel; Martin D Pickel; Neil D Christensen
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 8.  HPV as a model for the development of prophylactic and therapeutic cancer vaccines.

Authors:  Raed N Samara; Samir N Khleif
Journal:  Curr Mol Med       Date:  2009-08       Impact factor: 2.222

9.  Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue.

Authors:  Nancy M Cladel; Lynn R Budgeon; Karla K Balogh; Timothy K Cooper; Jiafen Hu; Neil D Christensen
Journal:  Virology       Date:  2015-11-21       Impact factor: 3.616

Review 10.  Recent advances in preclinical model systems for papillomaviruses.

Authors:  Neil D Christensen; Lynn R Budgeon; Nancy M Cladel; Jiafen Hu
Journal:  Virus Res       Date:  2016-12-09       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.